Beta-adrenergic antagonist
Term · Oncology and biomedicine · MLC-T-ONC-001009
A type of drug that blocks the action of substances, such as adrenaline, on nerve cells and causes blood vessels to relax and dilate (widen). This allows blood to flow more easily and lowers blood pressure and the heart rate. Beta-adrenergic antagonists are used to treat high blood pressure, chest pain (angina), abnormal heart rate (arrhythmia), congestive heart failure, and several other conditions. They may also shrink certain types of vascular tumors, such as hemangiomas. Also called beta-adrenergic blocking agent and beta-blocker.
| Identifier | MLC-T-ONC-001009 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | beta-adrenergic blocking agent; beta-blocker |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001009",
"term": "Beta-adrenergic antagonist",
"field": "Oncology and biomedicine",
"definition": "A type of drug that blocks the action of substances, such as adrenaline, on nerve cells and causes blood vessels to relax and dilate (widen). This allows blood to flow more easily and lowers blood pressure and the heart rate. Beta-adrenergic antagonists are used to treat high blood pressure, chest pain (angina), abnormal heart rate (arrhythmia), congestive heart failure, and several other conditions. They may also shrink certain types of vascular tumors, such as hemangiomas. Also called beta-adrenergic blocking agent and beta-blocker.",
"synonyms": [
"beta-adrenergic blocking agent",
"beta-blocker"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/beta-adrenergic-antagonist/"
}
Record 3,474 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.